Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.92M Sell
15,573
-2,142
-12% -$461K 0.27% 84
2026
Q1
$3.85M Sell
17,715
-479
-3% -$106K 0.29% 76
2025
Q4
$4.16M Buy
18,194
+231
+1% +$52.6K 0.31% 63
2025
Q3
$4.16M Sell
17,963
-410
-2% -$83.5K 0.32% 58
2025
Q2
$3.41M Sell
18,373
-47
-0.3% -$8.73K 0.28% 79
2025
Q1
$3.86M Buy
18,420
+18,402
+102,233% +$3.58M 0.33% 61
2024
Q4
$3.36K Sell
18
-19,009
-100% -$3.49M 0.31% 68
2024
Q3
$3.76M Sell
19,027
-1,017
-5% -$190K 0.32% 63
2024
Q2
$3.44M Buy
20,044
+206
+1% +$34.1K 0.31% 65
2024
Q1
$3.61M Sell
19,838
-1,223
-6% -$211K 0.34% 54
2023
Q4
$3.26M Sell
21,061
-293
-1% -$42.7K 0.33% 62
2023
Q3
$3.18M Buy
+21,354
New +$3.13M 0.35% 54

Other funds holding ABBV

NBC Securities's ABBV Position: Q2 2026 in Review

NBC Securities reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $461K and leaving 15,573 shares worth $3.92M. The position accounts for 0.27% of the portfolio, ranked #84.

NBC Securities first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.16M in Q3 2025. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NBC Securities held 15,573 shares of AbbVie worth $3.92M as of Q2 2026.
  • NBC Securities sold 2,142 AbbVie shares in Q2 2026, an estimated $461K.
  • AbbVie made up 0.27% of NBC Securities's portfolio in Q2 2026, its #84 holding.
  • NBC Securities first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's AbbVie position peaked at $4.16M in Q3 2025.
  • 1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.